Reproductive Endocrinology
News
FDA expands Essure’s postmarketing surveillance study
The study now will run for 5 years, and the cohort will be expanded to include any woman who receives the device before it’s pulled from U.S....
Conference Coverage
Infertility appears to be increased among women with epilepsy
NEW ORLEANS – An analysis finds an infertility rate of 9.2% among women with epilepsy, compared with 6.0% in the...
From the Journals
PCOS linked to increased cancer risk in premenopausal women
The increased risks appear to subside after menopause.
Commentary
NIH director expresses concern over CRISPR-cas9 baby claim
“Lest there be any doubt, and as we have stated previously, NIH does not support the use of gene-editing technologies in human embryos.”
From the Journals
Levonorgestrel implant right after delivery does not affect breastfeeding, infant growth
There were similar rates of infant growth in both groups at 6 months, and there were no significant between-group differences in time to...
Conference Coverage
CKD, and even dialysis, may not be barriers to pregnancy
Nephrologist urges colleagues to get a grip on how to counsel patients of child-bearing age.
News from the FDA/CDC
Endocrine Society raises concerns about FDA’s “safe” classification of bisphenol A in food containers
Results from the CLARITY-BPA Core Study show serious effects in humans of bisphenol A at low doses, despite claims from the FDA.
Feature
Study: Problems persist with APMs
Concerns reported in 2014 persisted into 2018 and were joined by new concerns over the pace of change and complexity as well as issues with two-...
Opinion
All children deserve support for their gender identities
Reports of youth detransitioning, which highlight physicians’ fears of making a mistake, obscure the more common – and positive – outcomes for...
From the Journals
Ulipristal reduces bleeding with contraceptive implant
Dr. Eve Espey says toxicity concerns must be addressed before a clinical roll out.
From the Journals
One-step gestational diabetes screening doesn’t improve outcomes
Revised protocol increased diagnoses, but also increased insulin use and pregnancy outcomes including labor induction and neonatal hyperglycemia...